share_log

Truist Securities Maintains Buy on CVS Health, Lowers Price Target to $60

Benzinga ·  Jan 6 08:19  · Ratings

Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $67 to $60.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment